Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
about
An update of biochemical markers of hepatocellular carcinomaTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsOncoproteomics: Trials and tribulations.Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsAptamer-Based Screens of Human Body Fluids for Biomarkers.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection.Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition.Computational identification of micro-structural variations and their proteogenomic consequences in cancer.Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression.
P2860
Q26752700-6A83FDDD-6C21-45F4-8DFC-12A65D8E9D37Q28085015-8CB3BAFC-1F96-4086-8A88-DCB28D227239Q35827653-A749EC54-C890-4649-B565-18FD192B5CBFQ36533665-DF5263B4-7C28-4BB2-B487-CDE31EEF7D8AQ36889137-9B88CB39-849C-4B57-81E6-474D25EA2B2AQ37200787-E59D0278-5F56-4757-8839-2AD3D70635E0Q37651691-D6D86EC0-51BE-4040-A33E-3D0A3D414C0FQ37688597-C015183D-19CC-4487-850E-158CE58CA6D3Q38777639-EA65C755-ED66-4B7A-B079-52DF0AF6265BQ38883226-3E544EEB-A8AC-4B27-8213-FBD6038C5EFFQ38883230-262B08D5-2DA0-4E59-83BF-1FCA0218D755Q38961285-0FFA4644-C1C1-4C92-BBA6-0332B7190B2EQ47264953-123CFB65-94DA-4DEA-BF8E-5F487F4B54CEQ50897636-49F6D52F-5D0F-4807-AF33-9AE4B9F61AD4
P2860
Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biomarker discovery for early ...... hepatitis C-infected patients.
@ast
Biomarker discovery for early ...... hepatitis C-infected patients.
@en
Biomarker discovery for early ...... hepatitis C-infected patients.
@nl
type
label
Biomarker discovery for early ...... hepatitis C-infected patients.
@ast
Biomarker discovery for early ...... hepatitis C-infected patients.
@en
Biomarker discovery for early ...... hepatitis C-infected patients.
@nl
prefLabel
Biomarker discovery for early ...... hepatitis C-infected patients.
@ast
Biomarker discovery for early ...... hepatitis C-infected patients.
@en
Biomarker discovery for early ...... hepatitis C-infected patients.
@nl
P2093
P2860
P356
P1476
Biomarker discovery for early ...... hepatitis C-infected patients.
@en
P2093
Cornelis Elferink
John R Petersen
Larry Denner
Luca Cicalese
Mehnaz G Mustafa
Ned Snyder
Sigmund J Haidacher
P2860
P304
P356
10.1074/MCP.M113.031252
P577
2013-09-05T00:00:00Z